Evans D, Fang J, Silvers T, Delosh R, Laudeman J, Ogle C
Cancer Chemother Pharmacol. 2019; 84(2):359-371.
PMID: 31102023
PMC: 8127868.
DOI: 10.1007/s00280-019-03863-w.
Rockwell S, Liu Y, Seow H, Ishiguro K, Baumann R, Penketh P
Int J Radiat Biol. 2011; 88(3):277-85.
PMID: 22111842
PMC: 3660845.
DOI: 10.3109/09553002.2012.638359.
Moore C
Antimicrob Agents Chemother. 1982; 21(4):595-600.
PMID: 6177286
PMC: 181948.
DOI: 10.1128/AAC.21.4.595.
Twentyman P, Bleehen N
Br J Cancer. 1974; 30(5):469-72.
PMID: 4143273
PMC: 2009321.
DOI: 10.1038/bjc.1974.222.
Iliakis G
Br J Cancer. 1987; 55(4):381-4.
PMID: 3580262
PMC: 2001692.
DOI: 10.1038/bjc.1987.76.
Growth phase dependency of chromatin cleavage and degradation by bleomycin.
Moore C, Jones C, Wall L
Antimicrob Agents Chemother. 1989; 33(9):1592-9.
PMID: 2479336
PMC: 172708.
DOI: 10.1128/AAC.33.9.1592.
Platinum-dye complexes inhibit repair of potentially lethal damage following bleomycin treatment.
Wang Y, Herman T, Teicher B
Br J Cancer. 1989; 59(5):722-6.
PMID: 2472165
PMC: 2247223.
DOI: 10.1038/bjc.1989.152.
Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment.
Holden S, Teicher B, Boeheim K, Weichselbaum R, Ervin T
Br J Cancer. 1987; 55(3):245-8.
PMID: 2436643
PMC: 2001757.
DOI: 10.1038/bjc.1987.47.
Short term high density systemic therapy for metastatic breast cancer.
Tormey D, Kline J, Palta M, Davis T, Love R, Carbone P
Breast Cancer Res Treat. 1985; 5(2):177-88.
PMID: 2410072
DOI: 10.1007/BF01805992.
Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.
Twentyman P, Bleehen N
Br J Cancer. 1975; 31(4):417-23.
PMID: 1156523
PMC: 2009450.
DOI: 10.1038/bjc.1975.80.
Studies with bleomycin and misonidazole on aerated and hypoxic cells.
Hall E
Br J Cancer. 1978; 37(2):254-60.
PMID: 75740
PMC: 2009591.
DOI: 10.1038/bjc.1978.34.
The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.
Twentyman P, Bleehen N
Br J Cancer. 1976; 33(3):320-8.
PMID: 57788
PMC: 2024992.
DOI: 10.1038/bjc.1976.46.
Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo.
Twentyman P, Bleehen N
Br J Cancer. 1975; 32(4):491-501.
PMID: 55271
PMC: 2024758.
DOI: 10.1038/bjc.1975.251.
Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation.
Hahn G, Braun J
Proc Natl Acad Sci U S A. 1975; 72(3):937-40.
PMID: 48253
PMC: 432437.
DOI: 10.1073/pnas.72.3.937.
